Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 78 (2), 291-5

Infant Growth and Health Outcomes Associated With 3 Compared With 6 Mo of Exclusive Breastfeeding

Affiliations

Infant Growth and Health Outcomes Associated With 3 Compared With 6 Mo of Exclusive Breastfeeding

Michael S Kramer et al. Am J Clin Nutr.

Abstract

Background: Opinions and recommendations about the optimal duration of exclusive breastfeeding have been strongly divided, but few published studies have provided direct evidence on the relative risks and benefits of different breastfeeding durations in recipient infants.

Objective: We examined the effects on infant growth and health of 3 compared with 6 mo of exclusive breastfeeding.

Design: We conducted an observational cohort study nested within a large randomized trial in Belarus by comparing 2862 infants exclusively breastfed for 3 mo (with continued mixed breastfeeding through >/= 6 mo) with 621 infants who were exclusively breastfed for >/= 6 mo. Regression to the mean, within-cluster correlation, and cluster- and individual-level confounding variables were accounted for by using multilevel regression analyses.

Results: From 3 to 6 mo, weight gain was slightly greater in the 3-mo group [difference: 29 g/mo (95% CI: 13, 45 g/mo)], as was length gain [difference: 1.1 mm (0.5, 1.6 mm)], but the 6-mo group had a faster length gain from 9 to 12 mo [difference: 0.9 mm/mo (0.3, 1.5 mm/mo)] and a larger head circumference at 12 mo [difference: 0.19 cm (0.07, 0.31 cm)]. A significant reduction in the incidence density of gastrointestinal infection was observed during the period from 3 to 6 mo in the 6-mo group [adjusted incidence density ratio: 0.35 (0.13, 0.96)], but no significant differences in risk of respiratory infectious outcomes or atopic eczema were apparent.

Conclusions: Exclusive breastfeeding for 6 mo is associated with a lower risk of gastrointestinal infection and no demonstrable adverse health effects in the first year of life.

Similar articles

  • Optimal Duration of Exclusive Breastfeeding
    MS Kramer et al. Cochrane Database Syst Rev (1), CD003517. PMID 11869667. - Review
    : We found no objective evidence of a 'weanling's dilemma'. Infants who are exclusively breastfed for six months experience less morbidity from gastrointestinal infection …
  • Optimal Duration of Exclusive Breastfeeding
    MS Kramer et al. Cochrane Database Syst Rev (8), CD003517. PMID 22895934. - Review
    Infants who are exclusively breastfed for six months experience less morbidity from gastrointestinal infection than those who are partially breastfed as of three or four …
  • The Optimal Duration of Exclusive Breastfeeding: A Systematic Review
    MS Kramer et al. Adv Exp Med Biol 554, 63-77. PMID 15384567. - Review
    Although the health benefits of breastfeeding are acknowledged widely, opinions and recommendations are divided on the optimal duration of exclusive breastfeeding. We sys …
  • Promotion of Breastfeeding Intervention Trial (PROBIT): A Randomized Trial in the Republic of Belarus
    MS Kramer et al. JAMA 285 (4), 413-20. PMID 11242425. - Clinical Trial
    Our experimental intervention increased the duration and degree (exclusivity) of breastfeeding and decreased the risk of gastrointestinal tract infection and atopic eczem …
  • Breastfeeding and Infant Growth: Biology or Bias?
    MS Kramer et al. Pediatrics 110 (2 Pt 1), 343-7. PMID 12165588. - Clinical Trial
    Our data, the first in humans based on a randomized experiment, suggest that prolonged and exclusive breastfeeding may actually accelerate weight and length gain in the f …
See all similar articles

Cited by 60 PubMed Central articles

See all "Cited by" articles

Publication types

Feedback